difference of tirzepatide and semaglutide vs. Tirzepatide: Which GLP-1 Is Right for You? Tirzepatide vs Semaglutide 2026: 22%

FDA approval in the United States is expected in 2025-2026, with Health Canada approval typically following 6-18 months after FDA approval

Mouse retinal organoid growth and maintenance in longer-term culture

Short courses of prednisolone typically have less impact on overall weight loss trajectory compared to longer-term therapy at higher doses

GLP-1 medications essentially amplify and extend those satiety signals, making it easier to maintain a caloric deficit without the constant hunger that makes dietary restriction so difficult to sustain

Brand-name GLP1 may be covered under some Medicare Part D or Medicare Advantage plans when prescribed for type 2 diabetes, depending on your plans formulary